ImmuPharma PLC (IMM)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
2.92p
Buy
3.09p
-0.015p (-0.48%)
ImmuPharma PLC is a drug discovery and development company. The company along with its subsidiaries is engaged in the research and development of novel drugs based on peptide therapeutics to treat serious medical conditions including autoimmune diseases.
Prices updated at 07 May 2025, 17:09 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
01 Apr 202501 Apr 202514 Mar 202513 Mar 202521 Feb 202513 Feb 202528 Jan 202509 Jan 202508 Jan 202523 Dec 2024
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Sep 2025 |
| Annual general meeting | Jun 2025 |
| Final results | Jun 2025 |
| Annual report | Jun 2025 |
| Previous date | |
|---|---|
| Half yearly results | Sep 2024 |
| Annual general meeting | Jun 2024 |
| Final results | Jun 2024 |
| Annual report | Jun 2024 |
Company reports
31 Dec 2022
Annual Report 